In the last trading session, 2.55 million Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares changed hands as the company’s beta touched 1.72. With the company’s per share price at $20.53 changed hands at $4.25 or 26.11% during last session, the market valuation stood at $114.77M. TNXP’s last price was a discount, traded about -5712.37% off its 52-week high of $1193.28. The share price had its 52-week low at $6.76, which suggests the last value was 67.07% up since then. When we look at Tonix Pharmaceuticals Holding Corp’s average trading volume, we note the 10-day average is 2.9 million shares, with the 3-month average coming to 1.63 million.
Analysts gave the Tonix Pharmaceuticals Holding Corp (TNXP) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended TNXP as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight. Tonix Pharmaceuticals Holding Corp’s EPS for the current quarter is expected to be -640.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Instantly TNXP was in green as seen at the end of in last trading. With action 50.62%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -37.75%, with the 5-day performance at 50.62% in the green. However, in the 30-day time frame, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is 71.80% up. Looking at the short shares, we see there were 0.55 million shares sold at short interest cover period of 0.36 days.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
Year-over-year growth is forecast to reach 70.89% up from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 4.2M. 1 analysts are of the opinion that Tonix Pharmaceuticals Holding Corp’s revenue for the current quarter will be 4.3M. The company’s revenue for the corresponding quarters a year ago was 2.48M and 2.21M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 69.22%. The estimates for the next quarter sales put growth at 94.75%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 79.31%. The 2025 estimates are for Tonix Pharmaceuticals Holding Corp earnings to increase by 50.74%.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp is expected to release its next quarterly earnings report on 2024-Nov-11.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
The share float percentage for the stock currently stands at 3.32%.
Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund . With 10.45 shares estimated at $0.21 million under it, the former controlled 0.19% of total outstanding shares. On the other hand, Fidelity Total Market Index Fund held about 0.07% of the shares, roughly 4.03 shares worth around $82797.0.
